Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice

IF 0.5 Q4 PRIMARY HEALTH CARE Family Medicine and Primary Care Review Pub Date : 2023-01-01 DOI:10.5114/fmpcr.2023.130097

Dagmara Mirowska-Guzel, Magdalena Niedzielko, Rafał Kułakowski

{"title":"Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice","authors":"Dagmara Mirowska-Guzel, Magdalena Niedzielko, Rafał Kułakowski","doi":"10.5114/fmpcr.2023.130097","DOIUrl":null,"url":null,"abstract":"AMA Mirowska-Guzel D, Niedzielko M, Kułakowski R. Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review. 2023;25(3):353-359. doi:10.5114/fmpcr.2023.130097. APA Mirowska-Guzel, D., Niedzielko, M., & Kułakowski, R. (2023). Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review, 25(3), 353-359. https://doi.org/10.5114/fmpcr.2023.130097 Chicago Mirowska-Guzel, Dagmara, Magdalena Niedzielko, and Rafał Kułakowski. 2023. \"Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice\". Family Medicine & Primary Care Review 25 (3): 353-359. doi:10.5114/fmpcr.2023.130097. Harvard Mirowska-Guzel, D., Niedzielko, M., and Kułakowski, R. (2023). Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review, 25(3), pp.353-359. https://doi.org/10.5114/fmpcr.2023.130097 MLA Mirowska-Guzel, Dagmara et al. \"Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice.\" Family Medicine & Primary Care Review, vol. 25, no. 3, 2023, pp. 353-359. doi:10.5114/fmpcr.2023.130097. Vancouver Mirowska-Guzel D, Niedzielko M, Kułakowski R. Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review. 2023;25(3):353-359. doi:10.5114/fmpcr.2023.130097.","PeriodicalId":44481,"journal":{"name":"Family Medicine and Primary Care Review","volume":"39 1","pages":"0"},"PeriodicalIF":0.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Family Medicine and Primary Care Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/fmpcr.2023.130097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}

引用次数: 0

Abstract

AMA Mirowska-Guzel D, Niedzielko M, Kułakowski R. Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review. 2023;25(3):353-359. doi:10.5114/fmpcr.2023.130097. APA Mirowska-Guzel, D., Niedzielko, M., & Kułakowski, R. (2023). Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review, 25(3), 353-359. https://doi.org/10.5114/fmpcr.2023.130097 Chicago Mirowska-Guzel, Dagmara, Magdalena Niedzielko, and Rafał Kułakowski. 2023. "Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice". Family Medicine & Primary Care Review 25 (3): 353-359. doi:10.5114/fmpcr.2023.130097. Harvard Mirowska-Guzel, D., Niedzielko, M., and Kułakowski, R. (2023). Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review, 25(3), pp.353-359. https://doi.org/10.5114/fmpcr.2023.130097 MLA Mirowska-Guzel, Dagmara et al. "Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice." Family Medicine & Primary Care Review, vol. 25, no. 3, 2023, pp. 353-359. doi:10.5114/fmpcr.2023.130097. Vancouver Mirowska-Guzel D, Niedzielko M, Kułakowski R. Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice. Family Medicine & Primary Care Review. 2023;25(3):353-359. doi:10.5114/fmpcr.2023.130097.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

在一般实践中管理nirmatrelvir/ritonavir (Paxlovid)相互作用

AMA Mirowska-Guzel D, Niedzielko M, Kułakowski R. Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice.家庭医学与初级保健评论》。2023;25(3):353-359. doi:10.5114/fmpcr.2023.130097.APA Mirowska-Guzel, D., Niedzielko, M., & Kułakowski, R. (2023)。在全科实践中管理尼马瑞韦/利托那韦（帕克洛维）的相互作用。https://doi.org/10.5114/fmpcr.2023.130097 Chicago Mirowska-Guzel, Dagmara, Magdalena Niedzielko, and Rafał Kułakowski.2023."在全科诊疗中管理尼马瑞韦/利托那韦（Paxlovid）的相互作用》。家庭医学与初级保健评论 25 (3)：353-359. doi:10.5114/fmpcr.2023.130097.Harvard Mirowska-Guzel, D., Niedzielko, M., and Kułakowski, R. (2023).在全科诊疗中管理尼马瑞韦/利托那韦（Paxlovid）的相互作用。https://doi.org/10.5114/fmpcr.2023.130097 MLA Mirowska-Guzel, Dagmara et al. "Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice." Family Medicine & Primary Care Review, 25(3), pp.353-359.家庭医学与初级保健评论》，第 25 卷，第 3 期，2023 年，第 3 页。doi:10.5114/fmpcr.2023.130097.Vancouver Mirowska-Guzel D, Niedzielko M, Kułakowski R. Managing nirmatrelvir/ritonavir (Paxlovid) interactions in general practice.家庭医学与初级保健评论》。2023;25(3):353-359. doi:10.5114/fmpcr.2023.130097.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊